Retraction: Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies
- PMID: 37141216
- PMCID: PMC10159117
- DOI: 10.1371/journal.pone.0285567
Retraction: Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies
Retraction of
-
Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies.PLoS One. 2016 Aug 17;11(8):e0161150. doi: 10.1371/journal.pone.0161150. eCollection 2016. PLoS One. 2016. Retraction in: PLoS One. 2023 May 4;18(5):e0285567. doi: 10.1371/journal.pone.0285567 PMID: 27532124 Free PMC article. Retracted.
Similar articles
-
Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies.PLoS One. 2016 Aug 17;11(8):e0161150. doi: 10.1371/journal.pone.0161150. eCollection 2016. PLoS One. 2016. Retraction in: PLoS One. 2023 May 4;18(5):e0285567. doi: 10.1371/journal.pone.0285567 PMID: 27532124 Free PMC article. Retracted.
-
Clusterin overexpression and relapse-free survival in breast cancer.Anticancer Res. 2009 Oct;29(10):3909-12. Anticancer Res. 2009. PMID: 19846927
-
Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma.Tumour Biol. 2016 Jan;37(1):999-1008. doi: 10.1007/s13277-015-3875-3. Epub 2015 Aug 12. Tumour Biol. 2016. PMID: 26264614
-
Role of secretory clusterin in hepatocarcinogenesis.Transl Gastroenterol Hepatol. 2018 Aug 1;3:48. doi: 10.21037/tgh.2018.07.13. eCollection 2018. Transl Gastroenterol Hepatol. 2018. PMID: 30221206 Free PMC article. Review.
-
Secretory Clusterin: A Promising Target for Chemoresistance of Hepatocellular Carcinoma.Mini Rev Med Chem. 2020;20(12):1153-1165. doi: 10.2174/1389557520666200331072122. Mini Rev Med Chem. 2020. PMID: 32228422 Review.
References
Publication types
LinkOut - more resources
Full Text Sources